Surgical management of pancreatic pseudocyst..by dr chris alumonaCHRIS ALUMONA
Pancreatic pseudocyst is the commonest cystic lesion of the pancreas but generally rare. It commonly complicates pancreatitis and resolves spontaneously with conservative management. Indications for intervention include complications and to rule out malignancy
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Surgical management of pancreatic pseudocyst..by dr chris alumonaCHRIS ALUMONA
Pancreatic pseudocyst is the commonest cystic lesion of the pancreas but generally rare. It commonly complicates pancreatitis and resolves spontaneously with conservative management. Indications for intervention include complications and to rule out malignancy
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. CASE STUDY
• A 40 y/o male who came in 2 weeks ago with
a one and a half month history of abdominal
pain at the left hypochondrial region. The pain
was sudden in onset and sharp.. It radiates to
the back and the right hypochondrial region. It
is severe at night. It is exacerbated by eating
food and being seated upright. It is relieved by
painkillers. Patient had one episode of loss of
consciousness due to the pain
3. Cont’d
• No history of trauma
• Constitutional symptoms absent apart from decreased
appetite.
• No history of vomiting, diarrhoea
• Past medical- admitted on 5/8/21 due to the same
problem. Was discharged on pain meds. The rest of the
medical history is non-remarkable
• Social
– Smoker with a 1 year pack history
– Alcohol consumption of 2 bottles/day of spirits
such as vodka for 15 years
• R.O.S- Non-remarkable
4. Cont’d
• General exam
– Pt was in a fair general condition; not wasted
– (JACCLWOD)
– Vitals BP 102/71 mmHg (normal), PR 132/min
(increased), Temp 36.7C, RR 19/min
• P/A
– Inspection- No obvious scars. Umbilicus inverted.
Obvious abdominal distension from the epigastric
region to the level of umbilicus. Cullen sign
negative. Grey Turner sign negative
5. Cont’d
– Palpation- Palpable mass at the epigastric region
that is tender. The mass was firm and fixed. It was
multinodular. Edges of the mass were not
palpated. The mass was non-pulsatile. Rovsing
sign negative. Psoas sign negative. Murphy sign
negative. No hepatomegaly, no splenomegaly
– Percussion- Dullness was elicited in the epigastric
and the umbilical region. It wasn’t shifting. The
rest of the abdomen was tympanic
– Auscultation- Bowel sounds were present at a rate
of 15/min (normal). No bruits heard.
6. Cont’d
• Other systems were non-remarkable
• DRE was non-remarkable
• Ix- FHG- normal, RFTs- creatinine decreased,
uric acid increased LFTs- albumin decreased,
GGT high, total protein high, RBS- 4.6mmol/L
• DDx?
7. DDx
• Pancreatitis (r/o through cullen and grey turner
negative)
• Appendicitis (r/o using Rovsing negative, Psoas
sign negative, no neutrophil shift to the left)
• Perforated duodenal ulcer (r/o since no
hematemesis)
• Cholecystitis (r/o since patient doesn’t have
jaundice, Murphy sign negative)
• Cholelithiasis (r/o because 5 F’s absent; fat, forty,
female, fair and fertile)
8. DDx
• Ca head of pancreas (r/i because of a mass at
the epigastric region)
• Acute liver disease (r/o since there’s no
hepatomegaly, no jaundice)
• Gastric adenocarcinoma (r/i because of mass
at epigastric region)
• Hepatocellular carcinoma (r/o because no
bruit heard upon auscultation of the liver)
9. DDx
• Alcoholic steatohepatitis (r/o due to absence of
jaundice)
• Diverticulitis (r/o because of the left hypochondrial
region pain, diverticulitis commonly occurs at left iliac
region)
• Urinary tract Infection (r/o since there’s no dysuria,
increased frequency)
• Ruptured abdominal aortic aneurysm (r/o because
patient had stable BP)
• Ca of the transverse colon
• Pancreatic pseudocyst (rare, but this is what our pt
had)
12. Definition
• Pancreatic pseudocyst is best defined as localized
fluid collections that are rich in amylase, lipase
and trypsin
• It has a non-epithilialized wall consisting of
fibrous and granulation tissue
• Usually appears several weeks after the onset of
pancreatitis.
• Rarely, chronic pancreatitis and trauma can cause
pseudocysts
• Usually located at the lesser peritoneal sac in
proximity to pancreas
13. Epidemiology
• Occurs commonly in the males
• May occur after pancreatitis in any age group
• In elderly, care should be taken not to confuse
cystic neoplasms with pseudocysts
14. Aetiology
• 75-85% of cases are caused by alcohol or
gallstone-related pancreatitis
• In children, trauma and pseudocysts have a
high correlation
• Other causes include drug toxicity
(sulphonamides, CPZ, Tetracyclines)
16. Pathophysiology
• Acute pancreatitis
– It causes ductular disruption, resulting in leakage
of pancreatic juice from inflammed area of gland,
accumulating in the space adjacent to the
pancreas
– Inflammatory response induces formation of
distinct cyst wall composed of granulation tissue,
and fibrosis
17. Pathophysiology
• Chronic pancreatitis
– Pancreatic duct is chronically obstructed
– Ongoing proximal pancreatic secretion leads to
secular dilation of duct leading to true retention
cyst
– Formed microcysts can eventually coalesce and
lose their epithelial lining as they enlarge
18.
19. History
• No specific set of symptoms that are
pathognomonic
• Consider the possibility of pseudocyst in a patient
who has had:
– Persistent abdominal pain
– Anorexia
– Abdominal mass after an episode of pancreatitis
– Pleural effusion
– Rarely, jaundice and sepsis (from infected pseudocyst)
20. Examination
• Tender abdomen
• Palpable mass in the abdomen
• Scleral icterus
• Pleural effusion
• Peritoneal signs suggest rupture of cyst
– Guarding
– Rebound tenderness
– Fever
21. Investigations
• Labs
– Baseline FHG, U/E/C’s, RBS, GXM
– Serum amylase, serum lipase elevated
– bilirubin and LFT’s elevated if biliary tree involved
How to differentiate tumour from pseudocyst
Tumour Pseudocyst
Carcinoembryonic
antigen
Elevated (greater
than 400ng/mL)
Low
Fluid viscosity Elevated Low
Amylase Low Elevated
Cytology Usually positive Usually negative
22. Investigations
• Radiological
– Abdominal CT- Gold standard. The usual finding is a
large cyst cavity in and around the pancreas. Multiple
cysts may be present. The pancreas may have
calcifications
– Abdominal U/S- may visualize cystic fluid collections in
and around the pancreas.
– Endoscopic U/S- helpful in detecting small portal
collaterals from otherwise undetected portal
hypertension that may increase bleeding risk with
transmural drainage
24. CT scan Pancreatic pseudocyst (yellow
circle) compressing on the stomach
(yellow arrow)
25. 2/3 of pancreatic pseudocysts occur at
tail of pancreas showing hypoechoicity
26. Management
• Goal of therapy is to avoid complications
• Most pseudocysts resolve without
interference and require supportive care
• Indications for surgical drainage:
– Complications (discussed at the end of the
presentation)
– Symptoms such as abdominal pain, vomiting,
abdominal distension
– Concern about possible malignancy
27. Surgical care
• Four types of drainage:
– Catheter drainage
– Transpapillary drainage
– Transmural drainage
– Surgical drainage
28. Surgical care
• Catheter drainage- Percutaneous catheter
placement is the procedure of choice for
treating infected pseudocysts. It is
contraindicated in patients who are poorly
compliant and cannot manage a catheter at
home. It is also contraindicated in patients
with strictures of main pancreatic duct.
Octreotide (somatostatin analogue) can be
used as an adjunct to catheter drainage to
reduce pancreatic exocrine function
29. Surgical care
• Transpapillary drainage- done via ERCP. It requires
cyst communication with the pancreatic duct
• Transmural drainage- This involves performing an
endoscopy and finding a bulge into the lumen of
the stomach or duodenum. The bulge is usually
caused by compression of the cyst. Access gained
to the cyst by cutting the wall of the
stomach/duodenum using a knife and then
placing a stent.
30. Surgical care
• Surgical drainage- It is the criterion standard
against which all therapies are measured. Internal
drainage is the procedure of choice. The type of
procedure depends on location of cyst:
– Cystogastrostomy- This is a surgery to create an
opening between a pancreatic pseudocyst and the
stomach when the cyst is in a suitable position to be
drained into the stomach. This conserves pancreatic
juices that would otherwise be lost. This was what
was done on the patient in the case study
31. – Cystojejunostomy- a connection is created
between the cyst and the jejunum so that the cyst
fluid is drained directly into the small intestine
– Cystoduodenostomy- A connection is created
between duodenum and the cyst to allow
drainage of fluid into the duodenum
32.
33. Complications
• Infection
• Hemorrhage- especially when the pseudocyst
injures the blood vessels
• Obstruction- blockage of the bile duct, duodenum
• Rupture- leading to peritonitis
• Thrombosis (most common is the splenic vein)
• Pseudoaneurysm formation (splenic artery most
common)